Neuropeptide B and Vaspin as New Biomarkers in Anorexia Nervosa
Table 1
Anthropometric and biochemical analyses in anorexia nervosa group (AN) and control group (CONTR).
Parameter [unit]
AN (n=46)
CONTR (n=30)
P value
Age [years]
15.7±1.8 16.0 (14.0;17.0)
15.4±1.5 15.0 (14.0;17.0)
NS
Body Mass [kg]
36.6±4.5 36.0 (33,0;40.0)
56.0±9.9 54.0 (49,6;58.0)
<0.000001
High [m]
1.616±0.067 1.620 (1.560;1.670)
1.650±0.042 1.640 (1.620;1.680)
NS
BMI [kg/m2]
13.97±1.14 14.20 (13.05;14.70)
20.54±3.57 20.58 (17.91;21.86)
<0.000001
BMI z-score
-4.019±1.501 -3.900 (-4.690;-2.890)
-0.129±1.024 -0.240 (-0.790;0.450)
<0.000001
Body Mass Index - for - age percentile
0.45±0.92 0.10 (0.10;0.10)
46.07±29.65 41.00 (21.00;67.00)
<0.000001
Neuropeptide B [ng/mL]
0.448±0.327 0.258 (0.135;0.885)
0.278±0.248 0.159 (0.110;0.295)
<0.05
Neuropeptide W [ng/mL]
0.273±0.145 0.196 (0.147;0.313)
0.203±0.120 0.161 (0.147;0.221)
NS
Parameters were presented as means±standard deviations and medians (with upper and lower quartile). n: number of people; p: level of statistical significance in Mann–Whitney test or Welch test (for, respectively, parametric and nonparametric date distributions); BMI: Body Mass Index; BMI z-score: Body Mass Index z-score; NS: not statistically significant difference.
